Published in Biochemistry on June 30, 1987
Positive co-operative binding at two weak lysine-binding sites governs the Glu-plasminogen conformational change. Biochem J (1992) 0.87
A high affinity interaction of plasminogen with fibrin is not essential for efficient activation by tissue-type plasminogen activator. J Biol Chem (2011) 0.85
Structural/functional properties of the Glu1-HSer57 N-terminal fragment of human plasminogen: conformational characterization and interaction with kringle domains. Protein Sci (1998) 0.77
Reconstitution of human DNA repair excision nuclease in a highly defined system. J Biol Chem (1995) 3.90
Human beta-defensin-1: an antimicrobial peptide of urogenital tissues. J Clin Invest (1998) 3.78
Rapid recovery of mycobacteria from clinical specimens using automated radiometric technic. Am J Clin Pathol (1984) 3.23
ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans. Proc Natl Acad Sci U S A (1995) 3.18
Bacteremia due to Mycobacterium avium-intracellulare in the acquired immunodeficiency syndrome. Ann Intern Med (1983) 3.06
Use of lysis-centrifugation (isolator) and radiometric (BACTEC) blood culture systems for the detection of mycobacteremia. J Clin Microbiol (1985) 2.86
Primary structure of elongation factor Tu from Escherichia coli. Proc Natl Acad Sci U S A (1980) 2.72
The structure of a complex of recombinant hirudin and human alpha-thrombin. Science (1990) 2.71
Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice. J Immunol (1989) 2.70
The structure of alpha-thrombin inhibited by a 15-mer single-stranded DNA aptamer. J Biol Chem (1993) 2.39
Myc requires distinct E2F activities to induce S phase and apoptosis. Mol Cell (2001) 2.29
Mouse myeloma tumor stem cells: a primary cell culture assay. J Natl Cancer Inst (1971) 2.17
Solid-phase Edman degradation. An automatic peptide sequencer. Eur J Biochem (1971) 2.14
Abdominal amyloidosis: spectrum of radiological findings. Clin Radiol (2003) 2.10
Structure of human des(1-45) factor Xa at 2.2 A resolution. J Mol Biol (1993) 2.07
Refined structure of the hirudin-thrombin complex. J Mol Biol (1991) 2.06
Human DNA repair excision nuclease. Analysis of the roles of the subunits involved in dual incisions by using anti-XPG and anti-ERCC1 antibodies. J Biol Chem (1995) 1.93
Structure of the hirugen and hirulog 1 complexes of alpha-thrombin. J Mol Biol (1991) 1.89
Replication protein A confers structure-specific endonuclease activities to the XPF-ERCC1 and XPG subunits of human DNA repair excision nuclease. J Biol Chem (1996) 1.87
The Na+ binding site of thrombin. J Biol Chem (1995) 1.77
Hepatic lipid peroxidation in vivo in rats with chronic iron overload. J Clin Invest (1983) 1.74
Postoperative chemoradiotherapy for gastric cancer. Ann Oncol (2003) 1.73
Development of mild extraction methods for the analysis of natural dyes in textiles of historical interest using LC-diode array detector-MS. Anal Chem (2005) 1.70
Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth. J Biol Chem (1997) 1.68
Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells. J Biol Chem (1996) 1.63
Solid-phase edman degradation: attachment of carboxyl-terminal homoserine peptides to an insoluble resin. FEBS Lett (1973) 1.61
Siderochromes from Pseudomonas fluorescens. I. Isolation and characterization. J Biol Chem (1982) 1.59
Can we predict spontaneous capsule passage after retention? A nationwide study to evaluate the incidence and clinical outcomes of capsule retention. Endoscopy (2007) 1.58
The crystal and molecular structure of triclinic tetraphenylporphyrin. J Am Chem Soc (1967) 1.57
Acidometric agar plate method for ampicillin susceptibility testing of Haemophilus influenzae. Antimicrob Agents Chemother (1978) 1.56
Endoscopic submucosal resection with double ligation technique for treatment of small rectal carcinoid tumors. Endoscopy (2006) 1.49
Morphological changes of the lateral meniscus in end-stage lateral compartment osteoarthritis of the knee. Osteoarthritis Cartilage (2011) 1.47
Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes. Biochemistry (1994) 1.46
The G-protein FlhF has a role in polar flagellar placement and general stress response induction in Pseudomonas putida. Mol Microbiol (2000) 1.46
Primary pontine hemorrhage: a new CT classification. Neurology (1992) 1.46
Comparison of the crystal structures of a flavodoxin in its three oxidation states at cryogenic temperatures. J Mol Biol (1991) 1.44
The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: changes accompanying activation and exosite binding to thrombin. Protein Sci (1994) 1.44
Laparoscopy-assisted distal gastrectomy with D2 lymph node dissection for gastric cancer: technical and oncologic aspects. Surg Endosc (2008) 1.43
Structural analysis of BAG1 cochaperone and its interactions with Hsc70 heat shock protein. Nat Struct Biol (2001) 1.43
Chromate-reducing properties of soluble flavoproteins from Pseudomonas putida and Escherichia coli. Appl Environ Microbiol (2004) 1.43
Comparison of BACTEC 13A medium and Du Pont isolator for detection of mycobacteremia. J Clin Microbiol (1988) 1.40
Dobutamine induced cardiogenic shock due to systolic anterior motion after mitral valve repair. Anaesth Intensive Care (2013) 1.38
An ambiguous structure of a DNA 15-mer thrombin complex. Acta Crystallogr D Biol Crystallogr (1996) 1.38
The Ca2+ ion and membrane binding structure of the Gla domain of Ca-prothrombin fragment 1. Biochemistry (1992) 1.37
Patterns of failure in gastric carcinoma after D2 gastrectomy and chemoradiotherapy: a radiation oncologist's view. Br J Cancer (2004) 1.36
A mutant of Escherichia coli with an altered elongation factor Tu. Proc Natl Acad Sci U S A (1976) 1.36
Structure-function relationships in an antifreeze polypeptide. The role of neutral, polar amino acids. J Biol Chem (1992) 1.36
Solitary pulmonary nodules in patients with extrapulmonary neoplasms. Radiology (2000) 1.35
The amino acid sequence of elongation factor Tu of Escherichia coli. The complete sequence. J Biol Chem (1981) 1.33
CHOP followed by involved field radiation: is it optimal for localized nasal natural killer/T-cell lymphoma? Ann Oncol (2001) 1.32
A model for binding of an antifreeze polypeptide to ice. Biophys J (1992) 1.31
Siderochromes from Pseudomonas fluorescens. II. Structural homology as revealed by NMR spectroscopy. J Biol Chem (1982) 1.30
Importance of testing stool specimens for Shiga toxins. J Clin Microbiol (2002) 1.30
Acute experimental allergic encephalomyelitis in SJL/J mice induced by a synthetic peptide of myelin proteolipid protein. J Neuropathol Exp Neurol (1990) 1.30
The molecular environment of the Na+ binding site of thrombin. Biophys Chem (1997) 1.29
Solution conformation of ferrichrome, a microbial iron transport cyclohexapeptide, as deduced by high resolution proton magnetic resonance. J Mol Biol (1970) 1.29
A protein kinase-A recognition sequence is structurally linked to transformation by p59v-rel and cytoplasmic retention of p68c-rel. Mol Cell Biol (1991) 1.29
The refinement and the structure of the dimer of alpha-chymotrypsin at 1.67-A resolution. J Biol Chem (1985) 1.27
Phosphorylated and unphosphorylated forms of human single-stranded DNA-binding protein are equally active in simian virus 40 DNA replication and in nucleotide excision repair. Proc Natl Acad Sci U S A (1995) 1.25
A rapid diagnosis of Campylobacter enteritis by direct smear examination. Am J Clin Pathol (1983) 1.24
Failure after core decompression in osteonecrosis of the femoral head. Int Orthop (2001) 1.23
Imipenem versus moxalactam in the treatment of serious infections. Antimicrob Agents Chemother (1983) 1.22
Nonequilibrium antifreeze peptides and the recrystallization of ice. Cryobiology (1995) 1.21
The structure of bovine brain myelin proteolipid and its organization in myelin. Proc Natl Acad Sci U S A (1984) 1.21
Differential effects and transport kinetics of ascorbate derivatives in leukemic cell lines. Anticancer Res (1998) 1.20
The structure of VanX reveals a novel amino-dipeptidase involved in mediating transposon-based vancomycin resistance. Mol Cell (1998) 1.19
Structure of 2-keto-3-deoxy-6-phosphogluconate aldolase at 2 . 8 A resolution. J Mol Biol (1982) 1.19
Rich variety of defects in ZnO via an attractive interaction between O vacancies and Zn interstitials: origin of n-type doping. Phys Rev Lett (2009) 1.19
Structures of the noncovalent complexes of human and bovine prothrombin fragment 2 with human PPACK-thrombin. Biochemistry (1993) 1.16
Albumin absorption and catabolism by isolated perfused proximal convoluted tubules of the rabbit. J Clin Invest (1984) 1.16
Identification of a rough strain of Escherichia coli O157:H7 that produces no detectable O157 antigen. J Clin Microbiol (1998) 1.15
Radioiodinated fatty acid esters in the management of hepatocellular carcinoma: preliminary findings. Cancer Chemother Pharmacol (1989) 1.14
Renal epithelial fluid secretion and cyst growth: the role of cyclic AMP. FASEB J (1989) 1.13
Solid-phase methods in protein sequence analysis. Methods Biochem Anal (1980) 1.13
Doping by large-size-mismatched impurities: the microscopic origin of arsenic- or antimony-doped p-type zinc oxide. Phys Rev Lett (2004) 1.13
The refined structure of the epsilon-aminocaproic acid complex of human plasminogen kringle 4. Biochemistry (1991) 1.11
Lymph node micrometastasis in node negative early gastric cancer. Eur J Surg Oncol (2008) 1.11
Proton magnetic resonance study of crambin, a hyperstable hydrophobic protein, at 250 and 600 MHz. Biochemistry (1980) 1.10
ABACUS, a direct method for protein NMR structure computation via assembly of fragments. Proteins (2005) 1.10
Structure and binding determinants of the recombinant kringle-2 domain of human plasminogen to an internal peptide from a group A Streptococcal surface protein. J Mol Biol (2001) 1.10
A novel, picomolar inhibitor of human immunodeficiency virus type 1 protease. J Med Chem (1996) 1.09
Interleukin 12 gene therapy of cancer by peritumoral injection of transduced autologous fibroblasts: outcome of a phase I study. Hum Gene Ther (2001) 1.09
Fat replacement of the exocrine pancreas. AJR Am J Roentgenol (1980) 1.08
Effect of metal binding on the conformation of enterobactin. A proton and carbon-13 nuclear magnetic resonance study. Biochemistry (1973) 1.08
Congenital cholesteatoma of mastoid origin. J Laryngol Otol (2007) 1.07
Structure of extracellular tissue factor complexed with factor VIIa inhibited with a BPTI mutant. J Mol Biol (1999) 1.07
Structure-function relationships in a type I antifreeze polypeptide. The role of threonine methyl and hydroxyl groups in antifreeze activity. J Biol Chem (1998) 1.07
New photoprotecting groups: desyl and p-hydroxyphenacyl phosphate and carboxylate esters. Methods Enzymol (1998) 1.07
Phase II study of high-dose lovastatin in patients with advanced gastric adenocarcinoma. Invest New Drugs (2001) 1.06
Expression of functionality of alpha-chymotrypsin. Effects of guanidine hydrochloride and urea in the onset of denaturation. Biochemistry (1978) 1.06
Multiple brown tumors in parathyroid carcinoma mimicking metastatic bone disease. Clin Nucl Med (1997) 1.06
Erysipelothrix endocarditis with cutaneous lesion. South Med J (1976) 1.06
Gene expression and protein levels of the stationary phase sigma factor, RpoS, in continuously-fed Pseudomonas aeruginosa biofilms. FEMS Microbiol Lett (2001) 1.06
Characterization of kringle domains of angiostatin as antagonists of endothelial cell migration, an important process in angiogenesis. FASEB J (1998) 1.05
Clinical features of peripheral T-cell lymphomas in 78 patients diagnosed according to the Revised European-American lymphoma (REAL) classification. Eur J Cancer (2002) 1.05
A synthetic peptide from myelin proteolipid protein induces experimental allergic encephalomyelitis. J Immunol (1988) 1.04
Three-dimensional structure of the kringle sequence: structure of prothrombin fragment 1. Biochemistry (1986) 1.04
Ceftazidime therapy of serious bacterial infections. Antimicrob Agents Chemother (1983) 1.03